Cargando…
Trends in the Development and Approval of Monoclonal Antibodies for Viral Infections
Monoclonal antibodies (mAbs) developed for either the prevention or treatment of viral diseases represent a small, but valuable, class of products. Since 1985, commercial firms have initiated clinical studies involving a total of 28 mAbs. To date, one product (palivizumab) has been approved and eigh...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100544/ https://www.ncbi.nlm.nih.gov/pubmed/17263584 http://dx.doi.org/10.2165/00063030-200721010-00001 |